Understanding the Role of Translational Control in Humanized Mouse Models for Medulloblastoma |
University of California San Francisco / Ozlem Aksoy, PhD |
Young Investigator Grants |
2015 |
California |
Function and Dependency of NFkB Activity in ZFTA-RELA Fusion Ependymoma |
Baylor College of Medicine / Austin Stuckert, MD |
Young Investigator Grants |
2021 |
Texas |
MDM2 as an Effector of Hedgehog Signaling in Brain Development and Medulloblastoma
|
Purdue University / Susan Mendrysa, PhD |
Young Investigator Grants |
2008 |
Indiana |
Targeting Protein Translation to Antagonize MYC-driven Neuroblastoma |
Children’s Hospital of Philadelphia / Andrea Flynn, MD |
Young Investigator Grants |
2017 |
Pennsylvania |
Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia |
National Cancer Institute / Christopher Chien, PhD |
Young Investigator Grants |
2014 |
Maryland |
Pax3-FKHR targets that enable bypass of cellular senescence in rhabdomyosarcoma.
|
Duke University Medical Center / Corinne Mary Linardic, MD, PhD |
Young Investigator Grants |
2006 |
North Carolina |
CD19 Delta Ex2 Isoform as a Target for Alternative Therapies in Relapsed Pediatric B-ALL |
Children’s Hospital of Philadelphia / Asen Bagashev, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
Characterization of the Role of Chromosome 1p Deletion in MYCN-Amplified Neuroblastoma |
University of California San Francisco / Miller Huang, PhD |
Young Investigator Grants |
2013 |
California |
Accessing Combinatorial Effect of PARP Inhibitor with DNA Damaging Agent in Rhabdomyosarcoma at Single Cell Resolution |
Massachusetts General Hospital / Chuan Yan, PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Identification and Targeting of Microenvironmental Factors Controlling Pediatric Leukemia |
New York University School of Medicine / Anastasia Tikhonova, PhD |
Young Investigator Grants |
2017 |
New York |